Xinyue Dou
Hangzhou, 310053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Protein acetylation modification in tissue fibrosis: Opportunities and challenges.
Journal: Pharmacology & therapeutics
Published: April 30, 2026
Protein S-palmitoylation: Potential strategy for inflammation-related diseases.
Journal: Journal of pharmaceutical analysis
Published: May 07, 2025
Targeting AKT to treat liver disease: Opportunities and challenges.
Journal: Biochemical pharmacology
Published: April 16, 2025
Taxifolin attenuates liver fibrosis by regulating the phosphorylation of NDRG1 at Thr328 via hepatocyte-stellate cell cross talk.
Journal: Acta pharmaceutica Sinica. B
Published: July 04, 2024
Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity.
Journal: Frontiers in pharmacology
Published: January 15, 2024
SIRT3: A potential therapeutic target for liver fibrosis.
Journal: Pharmacology & therapeutics
Published: December 16, 2023
Cornus officinalis with high pressure wine steaming enhanced anti-hepatic fibrosis: Possible through SIRT3-AMPK axis.
Journal: Journal of pharmaceutical analysis
Published: September 21, 2023
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.
Journal: Aging and disease
Published: June 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026